US Patent 11014909 Heteroaromatic compounds and their use as dopamine D1 ligands
Patent 11014909 was granted and assigned to Pfizer Limited on May, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+79 characters)
Article
Patent abstract
The present invention provides, in part, compounds of Formula I:
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
110149090
Date of Patent
May 25, 2021
0Patent Application Number
168806320
Date Filed
May 21, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
110149090
Date of Patent
May 25, 2021
0Patent Application Number
168806320
Date Filed
May 21, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 11014909 Heteroaromatic compounds and their use as dopamine D1 ligands
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11014909
Date of patent
May 25, 2021
Patent application number
16880632
Date Filed
May 21, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11014909 Heteroaromatic compounds and their use as dopamine D1 ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
